top of page
ÁREAS
CABEZA Y CUELLO | CEREBRALES
Opinión Personal
Opinión personal del Dr. Santiago Cabezas acerca de lo visto en ASCO 23 respecto a tumores cerebrales, de cabeza y cuello.
Lorem Ipsum 3
Cargo del Doctor Doctora
Highlight
Novedades en carcinoma nasofaríngeo, carcinoma escamoso de cabeza y cuello. También novedades en neuro-oncología
Lorem Ipsum 4
Cargo del Doctor Doctora
TOP ASBTRACTS
Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-overexpressing/amplified (HER2+) metastatic colorectal cancer (mCRC): Primary results from the multicenter, randomized, phase 2 DESTINY-CRC02 study.
AMPLIFY-201, a first-in-human safety and efficacy trial of adjuvant ELI-002 2P immunotherapy for patients with high-relapse risk with KRAS G12D- or G12R-mutated pancreatic and colorectal cancer.
PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048).
ÁREAS DE INTERÉS
Prensa
Traslacional | Nuevas Terapias
Sarcoma | Melanoma
Pulmón
bottom of page